Calystegine B2



Compound IDCDAMM02382
Common nameCalystegine B2
IUPAC name8-azabicyclo[3.2.1]octane-1,2,3,4-tetrol
Molecular formulaC7H13NO4

Experimental data

Retention time8.02
Adduct[2M+Na]+
Actual mz373.158
Theoretical mz373.157
Error1.83
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.665

Identifiers and class information

Inchi keyFXFBVZOJVHCEDO-UHFFFAOYNA-N
SmilesOC1C(O)C2NC(O)(CC2)C1O
SuperclassAlkaloids and derivatives
ClassTropane alkaloids

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)1
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)4
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)175.184
Computed dipole moment(dipole)4.653
Total solvent accessible surface area (SASA)349.628
Hydrophobic component of SASA (FOSA)163.567
Hydrophilic component of SASA (FISA)186.061
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)561.907
Number of hydrogen bond donors (donorHB)5
Number of hydrogen bond acceptors (accptHB)6.85
Free energy of solvation of dipole (dip^2/V)0.0385301
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0438097
Globularity descriptor (glob)0.941894
Predicted polarizability in cubic angstroms (QPpolrz)13.765
Predicted hexadecane/gas partition coefficient (QPlogPC16)6.225
Predicted octanol/gas partition coefficient (QPlogPoct)15.57
Predicted water/gas partition coefficient (QPlogPw)15.014
Predicted octanol/water partition coefficient (QPlogPo/w)-1.746
Predicted aqueous solubility (QPlogS)0.244
Conformation-independent predicted aqueous solubility (CIQPlogS)0.291
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.198
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)42.499
Predicted brain/blood partition coefficient (QPlogBB)-0.677
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)18.017
Predicted skin permeability, log Kp (QPlogKp)-6.627
PM3 calculated ionization potential (IP(ev))9.481
PM3 calculated electron affinity (EA(eV))-2.185
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)-0.777
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)45.868
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)100.849
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O00754MAN2B1Lysosomal alpha-mannosidaseT63156SwissTargetPrediction
P06280GLAAlpha-galactosidase AT61339SwissTargetPrediction
P16278GLB1Beta-galactosidase (by homology)T73134SwissTargetPrediction
Q16739UGCGCeramide glucosyltransferaseT14908SwissTargetPrediction
O43451MGAMMaltase-glucoamylaseT92777SwissTargetPrediction
P10253GAALysosomal alpha-glucosidase (by homology)T31514SwissTargetPrediction
P06280GLAAlpha-galactosidase AT61339SwissTargetPrediction
P06280GLAAlpha-galactosidase AT61339SwissTargetPrediction
P04062GBABeta-glucocerebrosidaseT84173SwissTargetPrediction
P06737PYGLLiver glycogen phosphorylaseT19184SwissTargetPrediction
Q9UMJ8GBA1Lysosomal acid glucosylceramidaseT63243SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T63156DI0242Lysosomal disease[ICD-11: 5C56]O00754MAN2B1
T61339DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]P06280GLA
T73134DI0242Lysosomal disease[ICD-11: 5C56]P16278GLB1
T14908DI0242Lysosomal disease[ICD-11: 5C56]Q16739UGCG
T14908DI0257Metabolic disorder[ICD-11: 5C50-5D2Z]Q16739UGCG
T92777DI0009Acute diabete complication[ICD-11: 5A2Y]O43451MGAM
T92777DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]O43451MGAM
T31514DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]P10253GAA
T61339DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]P06280GLA
T61339DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]P06280GLA
T84173DI0257Metabolic disorder[ICD-11: 5C50-5D2Z]P04062GBA
T63243DI0242Lysosomal disease[ICD-11: 5C56]Q9UMJ8GBA1

Copyright © 2025